Results 171 to 180 of about 9,342,565 (376)

Splenectomy for Hematologic Disease

, 1984
George Musser, Gary Lazar, William G. Hocking, Ronald W. Busuttil   +3 more
openalex   +2 more sources

Biopolymer Membranes for Osmotic Power Generation in Bionic Applications

Advanced Materials, EarlyView.
This review provides an overview of biopolymer‐based osmotic power generation for bionic applications. It uniquely bridges biopolymer membranes, reverse electrodialysis(RED), and bionic applications, addressing a critical research gap by integrating biopolymer membranes with RED technologies for biomedical use.
Changchun Yu, Fenghuan Jia, Dong Chen, Ziyi Wang, Pawel Wagner, Yong Liu, Caiyun Wang   +6 more
wiley   +1 more source

CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months

Blood Cancer Journal, 2023
Zhenzhen Yao, Bin Gu, Jia Chen, Yang Xu, Feng Chen, Shengli Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Suning Chen, Aining Sun, Lei Yu, Yanming Zhang, Depei Wu, Ying Wang   +14 more
doaj   +1 more source

Shared genetic architecture between autoimmune disorders and B-cell acute lymphoblastic leukemia: insights from large-scale genome-wide cross-trait analysis

BMC Medicine
Background To study the shared genetic structure between autoimmune diseases and B-cell acute lymphoblastic leukemia (B-ALL) and identify the shared risk loci and genes and genetic mechanisms involved. Methods Based on large-scale genome-wide association
Xinghao Yu, Yiyin Chen, Jia Chen, Yi Fan, Huimin Lu, Depei Wu, Yang Xu   +6 more
doaj   +1 more source

Expression of lymphocyte subsets in the bone marrow of patients with acute myeloid leukemia and its influence on prognosis

Zhongguo shuxue zazhi
[Objective] To explore the correlation between the composition of bone marrow lymphocyte subsets and the clinical attributes observed in de novo AML patients, as well as their influence on prognosis. [Methods] A detailed study was carried out on a cohort
NIE Jinhong, XIAO Jiebing, SHAO Yingchun, LI Chenghui, GAO Lu, MA Xiao, WU Xiaojin, ZHU Ziling   +7 more
doaj   +1 more source

Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease

, 1986
R.S. Hill, Petersen Fb, Rainer Storb, FR Appelbaum, K Doney, S Dahlberg, R Ramberg, Thomas Ed   +7 more
openalex   +1 more source

Meta-analysis of the association between low-affinityFcγ receptor gene polymorphisms and hematologic and autoimmune diseases [PDF]

, 2001
Thomas A Trikalinos, Fotini B. Karassa, John P. A. Ioannidis   +2 more
openalex   +1 more source

Heterogeneity Landscape of Circulating Tumor Cells in Clinical Utility

Advanced Therapeutics, EarlyView.
This study reports the heterogeneity spectrum of circulating tumor cells. The factors involved in the spectrum promote CTCs to overcome barriers in the metastatic cascade but impact the clinical outcome of cancer patients. In summary, the heterogeneities in association with CTCs ultimately reduce patient survival and facilitate increasing mortality of ...
Md Kowsar Alam, Lu Yanjun, Bee Luan Khoo, Tongxu Si, Heng Zou, Mengsu Yang   +5 more
wiley   +1 more source

Clinical Implementation of β-Tubulin Gene-Based Aspergillus Polymerase Chain Reaction for Enhanced Aspergillus Diagnosis in Patients with Hematologic Diseases: A Prospective Observational Study. [PDF]

J Fungi (Basel), 2023
Lee R, Kim WB, Cho SY, Nho D, Park C, Yoo IY, Park YJ, Lee DG.   +7 more
europepmc   +1 more source

SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1‐Mediated Transactivation of CD47

Advanced Science, EarlyView.
Cancer cell‐intrinsic SMYD3 orchestrates an immunosuppressive microenvironment and impairs the response to PD‐1 blockade by reprogramming immune cells landscape in the tumor microenvironment of clear cell renal cell carcinoma (ccRCC). The immunomodulatory function of SMYD3 is mediated via the SREBP1/CD47 pathway.
Zhengfang Liu, Xiumei Zhao, Maolin Zang, Huiyang Yuan, Xin Qin, Xiaofeng Li, Shuo Zhao, Ruirong Tan, Keqiang Yan, Li Liu, Yidong Fan, Ning Zhang, Benkang Shi, Bo Han, Shouzhen Chen   +14 more
wiley   +1 more source